The Valley Desk

NCT06441331 · Interventional trial

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Overall registry status Recruiting

Phase 1

Conditions CNS Tumors, GIST, Lymphoma, NETs, Peripheral Primitive Neuroectodermal Tumor, Rhabdomyosarcoma, Solid Tumor, Somatostatin Receptor Positive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov